News

Open Pathology Positions

Print

April 01, 2021

Faculty positions are open in bioinformatics, blood banking, cellular immunotherapy, Director of the Coagulation Laboratory, computational genomics and medicine, computational multi-omics diagnostics, EHR data analysis and phenotyping, epigenetics, gene therapy, machine learning/image analysis, molecular diagnostics, neurodegenerative disease research, neuropathology, pathology informatics, precision and computational diagnostics, RNA computational biology, surgical pathology (Cytopathology, GI, Gynecological, Head and Neck), and Chief of Pathology at PPMC.

Pathology & Laboratory Medicine Update on COVID-19 Testing

June 17, 2020

Below is the most recent announcement regarding COVID-19 from the Department of Pathology & Laboratory Medicine.
An archived list of past announcements can be found here.

Update from the Chair: Commitment in Our Community

Dear Members of the Pathology and Laboratory Medicine Community,

Penn Spinout Verismo Therapeutics Raises $16M to Advance Cell Therapies

May 05, 2021

Cellular therapy in preclinical development to target pancreatic cancer, mesothelioma and ovarian cancer.

Penn Medicine Team Uncovers Several Drugs That Could Treat COVID-19

April 03, 2021

Cell Reports study by Cherry Lab includes promising candidates already approved by FDA such as widely used transplant-rejection drug cyclosporine.

New Pathology Residents for 2021-22

March 19, 2021

2020 brought many challenges, including a completely virtual recruitment season with new processes and activities to engage pathology residency applicants with a variety of academic career goals in AP/CP, AP/NP, and CP only in unprecedented ways.

Giving & Philanthropy

February 26, 2021

The Department of Pathology and Laboratory Medicine gratefully appreciates any gift or donation to support its mission to advance biomedical research, educate future generations of clinicians, scientists, and healthcare providers, and improve patient care with the most advanced diagnostics and therapies available.

Penn Medicine Hires 50 New Laboratory Assistants in Partnership with West Philadelphia Skills Initiative

February 18, 2021

COVID-19 testing efforts expanded through the University City District’s West Philadelphia Skills Initiative (WPSI).

Cancer Cell Therapy Pioneer Dr. Carl June Named a 2021 Dan David Prize Laureate

February 15, 2021

$1 million "future" prize recognizes his contributions to molecular medicine, including his groundbreaking work in developing chimeric antigen receptor (CAR) T cell therapy.

Dr. Nicole Aqui Elected to 2020 Penn Medicine Academy of Master Clinicians

December 24, 2020

Academy recognizes Penn Medicine clinicians who exemplify the highest standards of clinical excellence, humanism and professionalism.

Professor Emeritus Prabodh K. Gupta, MD (1937-2020)

December 23, 2020

It is with profound sadness that we must share the news that our colleague Dr. Prabodh Gupta, MBBS, MD, Emeritus Professor of Pathology and Laboratory Medicine and a legend in Pathology and Cytopathology, has passed away.

Project Quaker Rolled Out for On-Campus COVID-19 Testing

December 16, 2020

Large-scale COVID-19 screening program known as Project Quaker is being rolled out across campus with the goal of conducting 40,000 saliva-based tests each week.

Two-Year Pilot Grant from the National Institute on Aging (NIA) to Study Genetics of Alzheimer’s Disease in People of Asian Heritage

December 14, 2020

$4.8 million grant for a new project called the Asian Cohort for Alzheimer’s Disease (ACAD) under the auspices of the Penn Neurodegeneration Genomics Center, the Genome Center for Alzheimer’s Disease (GCAD), the NIA Genetics of Alzheimer’s Disease Data Storage Site (NIAGADS), and the Penn Center for Global Genomics and Health Equity.

Penn Medicine Researchers Help Isolate Pathways of Resistance to Ibrutinib for Lymphoid Malignancies

December 07, 2020

Elenitoba-Johnson Lab et al. present new biomarker that identifies patients with aggressive lymphoma who don’t respond to precision therapy at American Society of Hematology Annual Meeting.

Drs. Carl June and Michael Milone Recipients of Agilent Thought Leader Award

November 25, 2020

Both were recognized for their joint contributions to the field of CAR T-cell mediated cancer immunotherapy.

Department Members Identified as Global Scientific Pioneers in Annual Highly Cited Researchers List

November 21, 2020

Drs. Carl June, John Lambris, Virginia M.Y. Lee, Bruce Levine, Leslie Shaw, John Trojanowski, and Xiaowei (George) Xu listed as researchers who have demonstrated significant influence in their chosen field through the publication of multiple highly cited papers during the last decade.

Open Pathology Positions

Print

Department News